Subjects with microvascular angina have longer GT repeats polymorphism in the haem oxygenase-1 gene promoter

References

• Arthur, H.M., et al., 2012. Women, cardiac syndrome X, and microvascular heart disease. Canadian journal of cardiology, 28 (2), S42–S49.
   PubMed Web of Science ®Google Scholar
• Ayer, A., et al., 2016. Heme oxygenases in cardiovascular health and disease. Physiological reviews, 96 (4), 1449–1508.
   PubMed Web of Science ®Google Scholar
• Bai, C.H., et al., 2010. Shorter GT repeat polymorphism in the heme oxygenase-1 gene promoter has protective effect on ischemic stroke in dyslipidemia patients. Journal of biomedical science, 17 (1), 12.
   PubMedGoogle Scholar
• Bao, W., et al., 2010. Association between heme oxygenase-1 gene promoter polymorphisms and type 2 diabetes mellitus: a HuGE review and meta-analysis. American journal of epidemiology, 172 (6), 631–636.
   PubMed Web of Science ®Google Scholar
• Beltrame, J.F., 2005. Advances in understanding the mechanisms of angina pectoris in cardiac syndrome X. European heart journal, 26 (10), 946–948.
   PubMed Web of Science ®Google Scholar
• Chen, Y.H., 2004. Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with angiographic restenosis after coronary stenting. European heart journal, 25 (1), 39–47.
   PubMed Web of Science ®Google Scholar
• Chen, Y.H., et al., 2002. Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Human genetics, 111 (1), 1–8.
   PubMed Web of Science ®Google Scholar
• Chen, Y.H., et al., 2008. Serum bilirubin and ferritin levels link heme oxygenase-1 gene promoter polymorphism and susceptibility to coronary artery disease in diabetic patients. Diabetes care, 31 (8), 1615–1620.
   PubMed Web of Science ®Google Scholar
• Daenen, K.E., et al., 2016. Association of HO-1 (GT)n promoter polymorphism and cardiovascular disease: a reanalysis of the literature. Canadian journal of cardiology, 32 (2), 160–168.
   PubMed Web of Science ®Google Scholar
• Dick, P., et al., 2005. Haem oxygenase-1 genotype and cardiovascular adverse events in patients with peripheral artery disease. European journal of clinical investigation, 35 (12), 731–737.
   PubMed Web of Science ®Google Scholar
• Dulak, J., et al., 2008. Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation, 117 (2), 231–241.
   PubMed Web of Science ®Google Scholar
• Exner, M., et al., 2001. Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with restenosis after percutaneous transluminal angioplasty. Journal of endovascular therapy, 8 (5), 433–440.
   PubMed Web of Science ®Google Scholar
• Furchgott, R.F., et al., 1991. Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Journal of vascular research, 28, 52–61.
   Google Scholar
• Huang, S.S., et al., 2010. Serum bilirubin predicts long-term clinical outcomes in patients with cardiac syndrome X. Heart, 96 (15), 1227–1232.
   PubMed Web of Science ®Google Scholar
• Idriss, N.K., et al., 2008. Hemoxygenase-1 in cardiovascular disease. Journal of the american college of cardiology, 52 (12), 971–978.
   PubMed Web of Science ®Google Scholar
• Kaneda, H., et al., 2002. Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arteriosclerosis, thrombosis, and vascular biology, 22 (10), 1680–1685.
   PubMed Web of Science ®Google Scholar
• Lanza, G.A., 2005. Cardiac syndrome X: a critical overview and future perspectives. Heart, 93 (2), 159–166.
   Web of Science ®Google Scholar
• Liang, K.W., et al., 2013. Shorter GT repeats in the heme oxygenase-1 gene promoter are associated with a lower severity score in coronary artery disease. J Chin med assoc, 76 (6), 312–318.
   PubMed Web of Science ®Google Scholar
• Liang, K.W., et al., 2015. Circulating adipokines and insulin resistance in subjects with combined cardiac and metabolic syndrome X. Diabetology and metabolic syndrome, 7 (1), 83.
   PubMedGoogle Scholar
• Liang, K.W., et al., 2017a. Differential expression of circulating vascular cell adhesion molecule-1 in subjects with coronary artery disease and cardiac syndrome X without known diabetes mellitus. Biomarkers, 22 (8), 798–804.
   PubMed Web of Science ®Google Scholar
• Liang, K.W., et al., 2017b. Post-challenge insulin concentration is useful for differentiating between coronary artery disease and cardiac syndrome X in subjects without known diabetes mellitus. Diabetology and metabolic syndrome, 9 (1), 10.
   PubMedGoogle Scholar
• Pechlaner, R., et al., 2015. Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with progressive atherosclerosis and incident cardiovascular disease. Arteriosclerosis, thrombosis, and vascular biology, 35 (1), 229–236.
   PubMed Web of Science ®Google Scholar
• Qiao, H., et al., 2014. Association between heme oxygenase 1 gene promoter polymorphisms and susceptibility to coronary artery disease: a HuGE review and meta-analysis. American journal of epidemiology, 179 (9), 1039–1048.
   PubMed Web of Science ®Google Scholar
• Schillinger, M., et al., 2002. Heme oxygenase-1 gene promoter polymorphism is associated with abdominal aortic aneurysm. Thrombosis research, 106 (2), 131–136.
   PubMed Web of Science ®Google Scholar
• Serruys, P.W., et al., 2009. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. New England journal of medicine, 360 (10), 961–972.
   PubMed Web of Science ®Google Scholar
• Singh, M., et al., 2010. Cardiac syndrome X: current concepts. International journal of cardiology, 142 (2), 113–119.
   PubMed Web of Science ®Google Scholar
• Taha, H., et al., 2010. Role of heme oxygenase-1 in human endothelial cells: lesson from the promoter allelic variants. Arteriosclerosis, thrombosis, and vascular biology, 30 (8), 1634–1641.
   PubMed Web of Science ®Google Scholar
• Vermeltfoort, I.A., et al., 2010. Definitions and incidence of cardiac syndrome X: review and analysis of clinical data. Clinical research in cardiology, 99 (8), 475–481.
   PubMed Web of Science ®Google Scholar
• Wang, C.Y., et al., 2010. Heme oxygenase-1 in cardiovascular diseases: molecular mechanisms and clinical perspectives. Chang gung med J, 33 (1), 13–24.
   PubMedGoogle Scholar